Home
#Global Trends
#Vietnam
#M&A
#Regulations
#Knowledge
Newletter
Events

Home
#Global Trends
#Vietnam
#M&A
#Regulations
#Knowledge
Newletter
Events

Category: Uncategorized

EUROPE DOES NOT LACK SCIENCE — IT IS LOSING THE RACE TO TURN SCIENCE INTO MEDICINES

23/09/2026 Published by HealthBiz

Key Development Europe still has world-class universities, scientists, manufacturing capabilities and pharmaceutical companies. The problem is that more capital, clinical... Read more

Tags: #Global Trends

LILLY PUTS $6.5 BILLION INTO HOUSTON: PHARMA COMPETITION IS SHIFTING FROM OWNING GREAT DRUGS TO OWNING THE CAPACITY TO MAKE THEM

23/09/2026 Published by HealthBiz

Key Development A $6.5 billion API facility signals that Lilly no longer treats manufacturing as simply a downstream function supporting... Read more

Category: Uncategorized

Tags: #Global Trends

DAZODALIBEP WINS PHASE 3: THE SJÖGREN’S RACE IS SHIFTING FROM “IS THERE A DRUG?” TO “WHICH PHENOTYPE SHOULD BE TREATED?”

23/09/2026 Published by HealthBiz

Key Development There is still no FDA-approved therapy specifically designed to treat Sjögren's disease. A successful Phase 3 trial therefore... Read more

Category: Uncategorized

Tags: #Global Trends

PHARMACITY LAUNCHES CHRONIC CARE CLUB: RETAIL PHARMACY IS MOVING FROM A POINT OF SALE TO A LONG-TERM CARE TOUCHPOINT

23/09/2026 Published by HealthBiz

Key Development A chronic-disease patient may see a physician only a few times a year, but medication use and self-management... Read more

Category: Uncategorized

Tags: #Vietnam

1,268 HOSPITALS HAVE ADOPTED ELECTRONIC MEDICAL RECORDS: THE NEXT BOTTLENECK IS NOT DIGITIZATION — IT IS SHARED DATA

22/09/2026 Published by HealthBiz

Key Development As of September 19, 2026, 1,268 of Vietnam's 1,650 public and private hospitals had participated in electronic medical... Read more

Category: Uncategorized

Tags: #Vietnam

IAMBIC FILES FOR IPO: AI MAY SHORTEN DRUG DISCOVERY — BUT THE MARKET NOW WANTS PROOF IT CAN MAKE BETTER DRUGS

22/09/2026 Published by HealthBiz

Key Development Less than two years from program launch to the clinic, compared with the roughly six-year industry benchmark cited... Read more

Category: Uncategorized

Tags: #Global Trends

ADARX TARGETS A $1.74 BILLION VALUATION: ARE INVESTORS PAYING FOR A PHASE 3 DRUG — OR AN ENTIRE RNA PLATFORM?

22/09/2026 Published by HealthBiz

Key Development A $1.74 billion valuation for a biotech with no commercial product might appear aggressive. But ADARx enters the... Read more

Category: Uncategorized

Tags: #Global Trends

J&J’S $14.6B NEUROSCIENCE GAMBIT PAYS OFF: CAPLYTA CONQUERS BIPOLAR MANIA IN PHASE 3 TRIAL

22/09/2026 Published by HealthBiz

Key Development Johnson & Johnson (J&J) has unveiled pivotal Phase 3 data (Study 451) demonstrating that lumateperone (Caplyta) significantly curtails... Read more

Category: Uncategorized

Tags: #Global Trends

VIETNAM HOSTS AOC 2026: THE REAL OPPORTUNITY IS NOT THE CONFERENCE — IT IS TURNING OPTOMETRY INTO PRIMARY EYE-CARE INFRASTRUCTURE

22/09/2026 Published by HealthBiz

Key Development An estimated 28.8% of Vietnamese schoolchildren have myopia, according to a recent meta-analysis. Against that backdrop, Vietnam's first... Read more

Category: Uncategorized

Tags: #Vietnam

Posts pagination

Previous page Page 1 … Page 15 Page 16 Page 17 … Page 224 Next page

Facebook

Map

Workday: Monday to Friday
Working hours: 8am to 5pm
Address: 8th floor, Hyco 4 building, 205A Nguyen Xi Street, Binh Thanh Ward, HCMC

Please enable JavaScript in your browser to complete this form.

Email

Email *

Get Your Weekly Market Insights Stay informed on Vietnam's market & Healthcare Alliance updates

Category: Uncategorized

Facebook

Map

Online Members